Globally, one in five women between age 30 and 50 suffer from excessive menstrual bleeding. Excessive menstrual bleeding can have a significant impact on a woman’s quality of life by disrupting family, social, personal and professional activities. This represents a very large opportunity for enhanced clinical outcomes, with over 8 million women impacted in the U.S. alone.
Headquartered in Redwood City, CA, AEGEA Medical, Inc. is developing a new proprietary system for the treatment of excessive menstrual bleeding. The AEGEA Vapor System™ delivers energy-dense water vapor into the uterine cavity to ablate the endometrial lining. AEGEA’s patented vapor method delivers controlled thermal energy to ablate tissue rapidly and completely.